Search for dissertations about: "ERK1 2 signalling"
Showing result 1 - 5 of 19 swedish dissertations containing the words ERK1 2 signalling.
-
1. β-adrenergic stimulation of VEGF gene expression : intracellular signalling pathways
Abstract : In the present study, the intracellular signalling pathway mediating ß-adrenergic stimulation of the expression of the vascular endothelial growth factor (VEGF) gene was investigated.VEGF is an activator of angiogenesis, the formation of new blood vessels, and is considered to be a major regulator of both physiologically and pathologically related angiogenesis, as well as being essential for development of the vascular system. READ MORE
-
2. Injury-Induced Signalling in Arterial Smooth Muscle Cells
Abstract : The vascular wall is an active, elastic and integrated organ made up of cellular and extracellular matrix (ECM) components. It is not a static organ; the components dynamically change and reorganize in response to physiological and pathological stimuli. Vascular injury induces a complex healing process, analogous to generalised wound healing. READ MORE
-
3. Injury-induced activation of vascular smooth muscle cells. Role of specific gene expression and intracellular signalling pathways
Abstract : Migration and proliferation of smooth muscle cells (SMC) are important events in the development of atherosclerosis and restenosis following angioplastic surgery. It is important to gain further knowledge about the mechanisms regulating SMC form and function in order to understand the underlying disease process. READ MORE
-
4. Mechanisms of stretch-induced growth and contractile differentiation in vascular smooth muscle
Abstract : Vascular smooth muscle can adapt to increased intraluminal pressure by remodelling and hypertrophy, as seen in hypertension. The molecular mechanisms responsible for this are still incompletely characterized. READ MORE
-
5. Prognostic role of tumour associated trypsin inhibitor in colorectal cancer patients
Abstract : Colorectal cancer (CRC) is one of the most common forms of human cancer worldwide with approximately 1 million new cases detected every year. CEA is currently the only accepted CRC marker incorporated into clinical practice, where it is used for early detection of metastasis in follow-up of patients having stage II and III disease, and for monitoring response to adjuvant treatment. READ MORE